Conventional therapies are inefficient in eliminating stem cells, which are AR‐negative3 and only show low proliferation and apoptosis rates.19 Therefore, it is important to find novel treatment options that eliminate the small population of tumor‐initiating cells that represent the top of the hierarchy in the bulk of PCa cells. Here, AR is linked to posterior cortical atrophy.